NPR

Test, Factor Ii G20210a Mutations, Genomic Dna Pcr

Product code
NPR
Device name
Test, Factor Ii G20210a Mutations, Genomic Dna Pcr
Device class
Class 2
21 CFR
21 CFR 864.7280
Medical specialty
Hematology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
1 (direct download)
510(k) clearances (all years, FDA)
5 (all years; only the last 3 years are listed here)

FDA classification definition

In vitro diagnostic test to detect the Factor II G20210A mutation in genomic DNA, as an aid to diagnosis in the evaluation of patients with suspected thrombophilia.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2025-02-21.

NumberDecision dateApplicantDevice nameSummary
K2502182025-02-21CepheidXpert® FII & FVPDF

1 summaries are archived here for direct download.

Official FDA classification page: NPR
Classification and pathway per current FDA publications. Data from openFDA (CC0).